KRIBIOLISA Double-Stranded RNA (dsRNA) ELISA (J2 based) Qualitative

SKU: KBBA56

Rs 144,300.00

Assay for the estimation of Double-Stranded RNA (dsRNA) (J2 based) in cell culture supernatant and other biological preparations

 

Guaranteed Safe Checkout

All our kits are manufactured under ISO 13485.

Assay Protocol Summary

  1. Bring all components to room temperature (18–25°C); use RNase-free consumables throughout
  2. Prepare Poly(I:C) standards: reconstitute lyophilised vial in 1 mL Sample Diluent (1,000 ng/mL), dilute to 200 ng/mL, then serial dilute (200 → 100 → 50 → 25 → 12.5 → 6.25 → 3.125 → 0 ng/mL)
  3. Add 100 µL standards or diluted samples to respective wells
  4. Seal plate; incubate 120 minutes at 37°C
  5. Wash 4× with Wash Buffer (1X)
  6. Add 100 µL K1 Detection:HRP Conjugate to all wells
  7. Seal plate; incubate 60 minutes at 37°C
  8. Wash 4× with Wash Buffer (1X)
  9. Add 100 µL TMB substrate; incubate 30 minutes at room temperature in dark (wells turn blue)
  10. Add 100 µL stop solution (blue → yellow)
  11. Read absorbance at 450 nm within 30 minutes

Frequently Asked Questions

1. What does the J2 antibody detect?
The J2 monoclonal antibody (IgG2a kappa) specifically binds double-stranded RNA molecules ≥40 base pairs in length. Detection is sequence-independent — the antibody recognises the A-form double-helical structure of dsRNA regardless of nucleotide composition. All naturally occurring dsRNA species investigated to date (40–50 species) are recognised, as well as synthetic analogs including poly(I:C) and poly(A):poly(U).

2. Can this kit detect dsRNA in mRNA preparations after IVT purification?
Yes. This is one of the primary designed applications. The kit is sensitive enough (LOD 0.3 ng/mL) to detect trace dsRNA remaining after HPLC or cellulose-based purification of IVT mRNA. The quantitative mode allows you to measure the effectiveness of each purification step and confirm specification limits are met. Dilute samples appropriately to bring residual dsRNA within the 3.125–200 ng/mL working range.

3. Will the kit detect mRNA itself?
No. Single-stranded mRNA is not detected by the J2 or K1 antibodies. The assay is highly selective for double-stranded RNA ≥40 bp and shows negligible reactivity with ssRNA, ssDNA, dsDNA, tRNA, siRNA, or short RNA duplexes below the 40 bp threshold.

4. What standard is used for quantification?
The kit includes lyophilised Poly(I:C) [polyinosinic:polycytidylic acid] as the dsRNA reference standard, reconstituted at 1,000 ng/mL. Poly(I:C) is a synthetic dsRNA analog widely used as a TLR3 agonist and immunostimulatory research tool. Note that J2’s affinity for poly(I:C) is approximately 10-fold lower than for some natural dsRNA antigens — quantification results for natural viral dsRNAs are expressed as ng/mL poly(I:C) equivalents.

5. What sample types are compatible?
The kit has been validated in mRNA-based preparations, nucleic acid extracts, human serum, human plasma, lysates, and viral culture supernatants. Matrix effect studies showed minimal interference in serum and plasma. Use RNase-free conditions for RNA-containing samples.

6. Can the kit detect dsRNA from specific viruses?
Yes — the J2 antibody has been used to detect dsRNA from Hepatitis C virus, Dengue virus, Chikungunya virus, Rhinovirus, Rabies virus, Poliovirus, Classic swine fever virus, Brome mosaic virus, and many others. The sequence-independent detection means any dsRNA replication intermediate ≥40 bp will be captured regardless of the virus species.

7. Is this a qualitative or quantitative assay?
Both. The kit supports qualitative screening (positive/negative relative to a positive control) and quantitative measurement (ng/mL from the standard curve). The format accommodates both lot release go/no-go testing and process characterisation workflows requiring actual concentration values.

8. What is the High Dose Hook Effect and how do I avoid it?
At very high dsRNA concentrations — most likely in samples from early in the purification process before dsRNA removal — the signal may appear lower than a diluted sample, indicating antibody saturation. If your undiluted sample reads lower than a 1:2 or 1:4 dilution, dilute further until results are consistent with the dilution factor. The kit has been validated to 1:32 dilution.

Downloads & Resources

  • Validation Guide (FDA/ICH ICH Q2(R1)) — Full validation data: sensitivity, linearity, precision, parallelism, matrix effect, specificity. Download PDF →
  • Product Datasheet / Kit Insert (Ver 1.3) — Full assay protocol, standard preparation, kit contents. Download PDF →

Additional information

Pack Type

5 x ELISA 96 wells

Sample Type

Cell Culture Supernatant and other biological samples

Assay Range

0.781 – 100 ng/ml

Sensitivity

~0.25 ng/ml

Interference

Preparations of the known factors were assayed for interference. No significant interference was observed.

Specificity

This assay recognises the indicated analyte within the assay range

Principle Of Assay

Double Antibody, Sandwich ELISA

Detection Method

Absorbance measured at 450nm, Colorimetric

Conjugate-Enzyme Reaction

Uses HRP enzyme conjugate with TMB chromogenic substrate for color development

Quality Certification

Validated as per KRISHGEN's Gold Ring 7-Point Program

KRISHGEN Mandate

High Performance Assays at Affordable Prices

Regulatory Status

Research Use Only

Shipping Temperature

Room Temperature / 2-8 degrees Celsius

Storage Temperature

if all the wells in the kit are not being used, store the unused wells in the foil pouch containing the desiccant pack, The kit and its components are to be stored as indicated in the IFU (instructions for use). To ensure quality of your results, well sealed and store at the indicated temperature.

ELISA Type

Double Antibody, Sandich ELISA

ELISA Interpretation

on request, Quantitative Results Intepretation (% Binding/OD450), Software (MS Excel) available, to support interpretation of results.

Shelf Life Available

8 -10 months at time of shipping

Alternate Names / Synonyms

Double-Stranded RNA; dsRNA; J2 based; RNA DNA vaccine

Research Area

Biosimilars; Monoclonal Antibodies; small molecules; therapeutic drug monitoring assays

Disclaimer

The data indicated herein with specifications are changed from time to time at time of production. Please refer the most current IFU (instructions for use) accompanying the kit.

Documents

KRIBIOLISA ds RNA J2-ELISA-Validation_Guide_2025_ver 1.0